Rigas B - Search Results

1

Is COX-2 a 'collateral' target in cancer prevention?

Kashfi K, Rigas B. Kashfi K, et al. Among authors: rigas b. Biochem Soc Trans. 2005 Aug;33(Pt 4):724-7. doi: 10.1042/BST0330724. Biochem Soc Trans. 2005. PMID: 16042585 Review.

2

Chemopreventive agents induce oxidative stress in cancer cells leading to COX-2 overexpression and COX-2-independent cell death.

Sun Y, Chen J, Rigas B. Sun Y, et al. Among authors: rigas b. Carcinogenesis. 2009 Jan;30(1):93-100. doi: 10.1093/carcin/bgn242. Epub 2008 Oct 24. Carcinogenesis. 2009. PMID: 18952595 Free PMC article.

3

NO-donating aspirin inhibits both the expression and catalytic activity of inducible nitric oxide synthase in HT-29 human colon cancer cells.

Spiegel A, Hundley TR, Chen J, Gao J, Ouyang N, Liu X, Go MF, Tsioulias GJ, Kashfi K, Rigas B. Spiegel A, et al. Among authors: rigas b. Biochem Pharmacol. 2005 Oct 1;70(7):993-1000. doi: 10.1016/j.bcp.2005.06.027. Biochem Pharmacol. 2005. PMID: 16105666

4

Cancer prevention: a new era beyond cyclooxygenase-2.

Rigas B, Kashfi K. Rigas B, et al. J Pharmacol Exp Ther. 2005 Jul;314(1):1-8. doi: 10.1124/jpet.104.080564. Epub 2005 Apr 1. J Pharmacol Exp Ther. 2005. PMID: 15805430 Review.

5

The role of NSAIDs in the prevention of colon cancer.

Rayyan Y, Williams J, Rigas B. Rayyan Y, et al. Among authors: rigas b. Cancer Invest. 2002;20(7-8):1002-11. doi: 10.1081/cnv-120005917. Cancer Invest. 2002. PMID: 12449734 Review. No abstract available.

6

Development of novel agents based on nitric oxide for the control of colon cancer.

Kozoni V, Rosenberg T, Rigas B. Kozoni V, et al. Among authors: rigas b. Acta Pharmacol Sin. 2007 Sep;28(9):1429-33. doi: 10.1111/j.1745-7254.2007.00696.x. Acta Pharmacol Sin. 2007. PMID: 17723176 Review.

7

The mechanism of action of nitric oxide-donating aspirin.

Kashfi K, Rigas B. Kashfi K, et al. Among authors: rigas b. Biochem Biophys Res Commun. 2007 Jul 13;358(4):1096-101. doi: 10.1016/j.bbrc.2007.05.038. Epub 2007 May 15. Biochem Biophys Res Commun. 2007. PMID: 17512900

8

Nitric oxide-donating aspirin inhibits colon cancer cell growth via mitogen-activated protein kinase activation.

Hundley TR, Rigas B. Hundley TR, et al. Among authors: rigas b. J Pharmacol Exp Ther. 2006 Jan;316(1):25-34. doi: 10.1124/jpet.105.091363. Epub 2005 Sep 16. J Pharmacol Exp Ther. 2006. PMID: 16169935

9

Non-COX-2 targets and cancer: expanding the molecular target repertoire of chemoprevention.

Kashfi K, Rigas B. Kashfi K, et al. Among authors: rigas b. Biochem Pharmacol. 2005 Oct 1;70(7):969-86. doi: 10.1016/j.bcp.2005.05.004. Biochem Pharmacol. 2005. PMID: 15949789 Review.

10

NO-donating aspirin inhibits the growth of leukemic Jurkat cells and modulates beta-catenin expression.

Nath N, Labaze G, Rigas B, Kashfi K. Nath N, et al. Among authors: rigas b. Biochem Biophys Res Commun. 2005 Jan 7;326(1):93-9. doi: 10.1016/j.bbrc.2004.11.009. Biochem Biophys Res Commun. 2005. PMID: 15567157

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results